News EU drug regulators concerned about Brexit impact European regulators concerned over impact of EMA move.
News Novartis less exposed to US pricing pressure, says Jimenez Europe and Asia account for a large share of company's income.
Views & Analysis Recent trends in ANDA litigation Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
News Allergan ‘not looking for big deals’ as growth slows Company will put its $27 billion to use, however
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.